This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters To the Editor

Is There a Real Difference Between the First Onset of Efficacy for Atypical Antipsychotic Monotherapies in Acute Bipolar Mania?

Tamas Treuer, MD, PhD, and Bruce R. Basson, MS

Published: October 14, 2005

Article Abstract

Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: Several points beyond those mentioned in Dr. Keck’s recent article1 are relevant to the appraisal of relative onset ofefficacy of atypical antipsychotics for mania. What Figure 1 ofDr. Keck’s article does demonstrate is that all of the atypicalstended to show faster onset of action versus placebo at the earliesttimepoint at which efficacy was first measured. For the olanzapinetrials, efficacy was not measured until after 7 days.2,3‘ ‹


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 66

Quick Links: Bipolar Disorder

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Original Research

Young-Adult Social Outcomes of Attention-Deficit/Hyperactivity Disorder

ADHD that persisted into young-adulthood was associated with poorer outcomes in terms of education, employment, and emotional...

Read More...